4.16 USD
▼+0.76-1.19%
盘后 4.25 +0.95%
2026-08-03
市值
$216.01M
市盈率
—
EPS
-2.17
股息率
—
52 周区间
1.32 – 7.75
成交量
210.54K
Beta
—
目标价
8.58
52W 低 1.3252W 高 7.75
价格走势
公司简介
Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-001, which is in a Phase 1/2 clinical trial for the treatment of urea cycle disorders. The company also develops CMP-002 for the treatment of SYNGAP1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015...